– Collaboration leverages Ascendis’ proprietary TransCon™ technologies and Novo Nordisk’s expertise in cardiometabolic diseases
Financial
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Acquisition to complement electrophysiology portfolio with solution to advance the treatment of complex atrial fibrillation MARLBOROUGH, Mass., Nov. 4, 2024 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire…
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
— Hospital Outpatient Prospective Payment System reimbursement rate doubled, expanding access to CCTA and supporting the technology’s superior accuracy and efficiency in cardiac care
LeMaitre Q3 2024 Financial Results
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance.
Q’Apel Medical Appoints Jay Hallinan as Chief Commercial Officer
Seasoned medical device executive to lead global commercial execution FREMONT, Calif., Oct. 31, 2024 /PRNewswire/ — Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, announced today the appointment of seasoned medical device…
GE HealthCare reports third quarter 2024 financial results
CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, “In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with […]
LivaNova Reports Third-Quarter 2024 Results
LONDON–(BUSINESS WIRE)–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2024 and raised full-year 2024 guidance. “LivaNova delivered strong revenue and operating income growth in the third quarter” Post this Financial Summary and Highlights(1) Third-quarter revenue of $318.1 million increased 11.2% […]
AtriCure Reports Third Quarter 2024 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2024 financial results. “Reconciliation of Non-GAAP Adjusted Income (Adjusted EBITDA)” Post this “Our broad-based growth in the third quarter reflects […]
Hello Heart Appoints Bill Otten as Commercial President
MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the digital leader in preventive heart health, today announced the appointment of healthcare industry veteran Bill Otten as Commercial President, reporting into Maayan Cohen, CEO and co-founder. He joins the company following another recent key hire, renowned cardiologist Jayne Morgan, MD who joined as VP, Medical Affairs. Together […]
Inari Medical Reports Third Quarter 2024 Financial Results
IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended September 30, 2024.
Recent
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
Rad AI Appoints Chief Operating Officer and First Chief Clinical Officer, Strengthening Operational and Clinical Strategy
Popular
- No commented posts yet